You are here

Article Text

Article menu
Download PDFPDF
DTB drug review
▼Icosapent ethyl for CV risk reduction

https://doi.org/10.1136/dtb.2024.000038

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests None declared. Refer to the online supplementary files to view the ICMJE form(s).

    • Provenance and peer review Commissioned; externally peer reviewed.